Epidemiology of neuroimmunological diseases

被引：1
|
作者：
Peter Flachenecker
机构：
[1] Neurological Rehabilitation Center „Quellenhof“,
来源：
Journal of Neurology | 2006年 / 253卷 / Suppl 5期
关键词：
epidemiology; inflammatory muscle diseases; myasthenia gravis; Guillain-Barré syndrome; multiple sclerosis; MS register;
D O I：
10.1007/s00415-006-5001-3
中图分类号：
学科分类号：
摘要：
This review gives an overview of various neuroimmunological diseases in terms of incidence and prevalence rates, age and sex distribution, and the frequency of subtypes, if applicable. The disorders selected for review are inflammatory muscle disorders (polymyositis, dermatomyositis and inclusion body myositis), myasthenia gravis, immune-mediated polyneuropathies (Guillain-Barré syndrome, chronic polyneuritis and vasculitic neuropathies), and multiple sclerosis.
引用
收藏
页码：v2 / v8
相关论文
共 50 条
  • [41] Transitional B cells involved in autoimmunity and their impact on neuroimmunological diseases
    Zhou, Yang
    Zhang, Ying
    Han, Jinming
    Yang, Mengge
    Zhu, Jie
    Jin, Tao
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [42] Fundamental mechanistic insights from rare but paradigmatic neuroimmunological diseases
    Wiendl, Heinz
    Gross, Catharina C.
    Bauer, Jan
    Merkler, Doron
    Prat, Alexandre
    Liblau, Roland
    NATURE REVIEWS NEUROLOGY, 2021, 17 (07) : 433 - 447
  • [43] Peripheral neuroimmunological Diseases - neuropathological Insights and clinical Perspectives (2024)
    Hoffmann, Sarah
    Holzer, Marie-Therese
    Preusse, Corinna
    Ruck, Tobias
    Ruffer, Nikolas
    Stascheit, Frauke
    Stenzel, Werner
    NERVENARZT, 2024, 95 (12): : 1181 - 1181
  • [44] Neurotrophic factors -: A tool for therapeutic strategies in neurological, neuropsychiatric and neuroimmunological diseases?
    Schulte-Herbrueggen, O.
    Braun, A.
    Rochlitzer, S.
    Jockers-Scheruebl, M. C.
    Hellweg, R.
    CURRENT MEDICINAL CHEMISTRY, 2007, 14 (22) : 2318 - 2329
  • [45] Immunoglobulin Class Switch of Anti-Glycolipid Antibodies in Neuroimmunological Diseases
    Samukawa, Makoto
    Kuwahara, Motoi
    Morikawa, Miyuki
    Ueno, Rino
    Hamada, Yukihiro
    Takada, Kazuo
    Mitsui, Yoshiyuki
    Kusunoki, Susumu
    ANNALS OF NEUROLOGY, 2016, 80 : S86 - S87
  • [46] COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable?
    Luigi Ferini-Strambi
    Maria Salsone
    Journal of Neurology, 2021, 268 : 409 - 419
  • [47] The impact of COVID-19 on diagnostic biomarkers in neuropsychiatric and neuroimmunological diseases: a review
    Dadkhah, Masoomeh
    Talei, Sahand
    Doostkamel, Donya
    Molaei, Soheila
    Rezaei, Nima
    REVIEWS IN THE NEUROSCIENCES, 2022, 33 (01) : 79 - 92
  • [48] Editorial: Bioinformatic Tools for the Detection and Identification of Mechanisms in Immune Cells of Neuroimmunological Diseases
    Dhanda, Sandeep Kumar
    Bose, Tanima
    FRONTIERS IN GENETICS, 2022, 13
  • [49] Einsatz von Rituximab in der Behandlung neuroimmunologischer ErkrankungenRituximab in treatment for neuroimmunological diseases
    A. Schröder
    G. Ellrichmann
    G. Chehab
    M. Schneider
    R.A. Linker
    R. Gold
    Der Nervenarzt, 2009, 80 (2)
  • [50] COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable?
    Ferini-Strambi, Luigi
    Salsone, Maria
    JOURNAL OF NEUROLOGY, 2021, 268 (02) : 409 - 419
12345